SLC11A2 and ovarian carcinoma: In the GENT database, SLC11A2 expression was upregulated in several cancer types (Fig. 1c), including adrenal, bladder, bone, breast, endometrial, colon, lung, lymphoma, prostate, gastric, and ovarian cancer.